Eko

company

About

Eko develops AI-powered digital tools to detect and monitor heart and lung disease

Details

Last Funding Type
Grant
Last Funding Money Raised
$2.70M
Industries
Artificial Intelligence,Health Care,Health Diagnostics,Machine Learning,Medical Device,mHealth,Software
Founded date
Jan 1, 2013
Number Of Employee
101 - 250
Operating Status
Active
Legal Name
Eko Devices, Inc.
Also Known As
Eko Devices,eko health

Eko is a digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its suite of AI-powered digital tools. Its FDA-cleared technology is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect disease earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko is headquartered in Oakland, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others.

Eko exists to ensure all patients have access to early heart and lung disease detection that improves and extends their lives.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
11
$128.20M
Eko has raised a total of $128.20M in funding over 2 rounds. Their latest funding was raised on Sep 20, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 20, 2022 Grant $2.70M 1 National Institutes of Health (NIH) Detail
Mar 22, 2022 Series C $30M 2 Morningside Venture Investments
PROOF Fund
Detail
Nov 9, 2020 Series C $65M 8 Highland Capital Partners
Questa Capital Management
Detail
Jul 22, 2020 Grant $2.70M 1 National Institutes of Health Detail
Sep 25, 2019 Series B $20M 7 Artis Ventures (AV) Detail

Employee Profiles

Number of Employee Profiles
21
Eko has 21 current employee profiles, including Executive Subbu Venkatraman
Executive
Executive
Advisor
Advisor
Executive